{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Warren",
      "state": "NJ",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "91259",
      "recalling_firm": "Glaxosmithkline Consumer Healthcare Holdings DBA Haleon",
      "address_1": "184 Liberty Corner Rd",
      "address_2": "N/A",
      "postal_code": "07059-6796",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA.",
      "recall_number": "D-0181-2023",
      "product_description": "Advil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b)\t200-count bottles (UPC 3 0573 0154 21 5), Pfizer, Madison, NJ 07940",
      "product_quantity": "321,246 tablets",
      "reason_for_recall": "Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back",
      "recall_initiation_date": "20221206",
      "center_classification_date": "20230125",
      "termination_date": "20240226",
      "report_date": "20230201",
      "code_info": "a) Lots EJ2218, EJ2219, EJ2220, Exp 09/2023; b) Lot 953D, Exp 05/2025",
      "more_code_info": ""
    }
  ]
}